NCT06790407 - Observational Metabolic Health Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

December 27, 2024

Study Completion Date

January 31, 2025

Conditions

Healthy

Interventions

DIETARY_SUPPLEMENT

Mimio Study Product

Active ingredients in the Mimio study product include Nicotinamide 250mg, Ultra-Micronized Palmitoylethanolamide 600mg, Oleoylethanolamide 400mg, Spermidine 8mg; Other Ingredients: Hydroxypropyl-Methylcellulose (capsule), Silicon Dioxide, Magnesium Stearate.

DIETARY_SUPPLEMENT

Placebo

Non-active study ingredients in the placebo include Micro Crystalline Cellulose 250mg, Hypromellose, Titanium Dioxide.

Trial Locations (1)

90034

People Science, Inc., Los Angeles

All Listed Sponsors

collaborator

People Science, Inc.

INDUSTRY

lead

Mimio Health, Inc.

INDUSTRY